Anne Seidlitz is a Professor of Pharmaceutical Technology at the Free University of Berlin since October 2024, previously holding the same position at Heinrich Heine University Düsseldorf (2021-2024). Affiliated with the Institute of Pharmacy , she leads the Seidlitz Pharmaceutical Technology Group , focusing on solid dosage forms and biorelevant drug release studies using 3D printing and hydrogel compartments . Doctorate in Pharmaceutical Technology (Greifswald, 2009) Habilitation in Natural Sciences (Greifswald, 2015) Qualified Person under German Medicines Act (AMG) Visiting Professorships: Hamburg, Jena Research Interests: Formulation development for implants , intravitreal injections , and subcutaneous delivery systems , with emphasis on biorelevant dissolution testing under physiological flow/movement conditions. Her group pioneers 3D-printed drug delivery devices and custom hydrogel models for vitreal , ear canal , and vascular implants . Publication Trends: Recent articles focus on thermal stability of steroids during extrusion, individualized implant design , and hydrogel compartments for non-oral dissolution testing . Key collaborations include EUFEPS Network and APV (Association for Pharmaceutical Process Engineering). Scientific Involvement: Member of EUFEPS Network on Bioavailability Scientific Council, German Federal Chamber of Pharmacists Active in APV (Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik) Student Supervision: Mentored 24+ theses including 3D-printed tablets , implant coatings , and vitreal drug distribution . Collaborates with institutions in Düsseldorf , Jena , and Hamburg .









